Global Value Stocks Estimated Up To 43.3% Below Intrinsic Value
Top 10 Undervalued Stocks Based On Cash Flows
Name
Current Price
Fair Value (Est)
Discount (Est)
Zhuhai CosMX Battery (SHSE:688772)
CN¥14.07
CN¥27.90
49.6%
Upsales Technology (OM:UPSALE)
SEK37.90
SEK75.38
49.7%
Shin Maint HoldingsLtd (TSE:6086)
¥1264.00
¥2321.99
45.6%
RVRC Holding (OM:RVRC)
SEK45.66
SEK91.03
49.8%
Hibino (TSE:2469)
¥2334.00
¥4673.98
50.1%
Forum Engineering (TSE:7088)
¥1207.00
¥2405.52
49.8%
doValue (BIT:DOV)
€2.488
€4.95
49.7%
Digital Workforce Services Oyj (HLSE:DWF)
€3.41
€6.80
49.8%
Atea (OB:ATEA)
NOK144.00
NOK286.37
49.7%
Absolent Air Care Group (OM:ABSO)
SEK243.00
SEK482.96
49.7%
Click here to see the full list of 482 stocks from our Undervalued Global Stocks Based On Cash Flows screener.
We're going to check out a few of the best picks from our screener tool.
TaewoongLtd
Overview: Taewoong Co., Ltd specializes in manufacturing and selling open-die forgings and ring rolled products both in South Korea and internationally, with a market cap of ₩765.28 billion.
Operations: Taewoong Co., Ltd generates its revenue through the production and sale of open-die forgings and ring rolled products, serving both domestic and international markets.
Estimated Discount To Fair Value: 31.4%
Taewoong Ltd. is trading at ₩38,250, significantly below its estimated fair value of ₩57,468.26, representing a 33.4% discount. Despite recent volatility in share price and a decline in profit margins from 8.9% to 5.1%, the company's earnings are projected to grow substantially at over 42% annually for the next three years, outpacing the Korean market's average growth rate of 20.8%.
The growth report we've compiled suggests that TaewoongLtd's future prospects could be on the up.
Unlock comprehensive insights into our analysis of TaewoongLtd stock in this financial health report.
HangzhouS MedTech
Overview: Hangzhou AGS MedTech Co., Ltd. operates in the research, development, production, sale, and service of endoscopic surgery equipment and accessories in China with a market cap of CN¥6.11 billion.
Operations: Hangzhou AGS MedTech Co., Ltd.'s revenue is primarily derived from its endoscopic surgery equipment and accessories business in China.
Estimated Discount To Fair Value: 24.9%
HangzhouS MedTech is trading at CN¥75.88, approximately 30.8% below its estimated fair value of CN¥109.66, indicating it is undervalued based on discounted cash flow analysis. While earnings are expected to grow significantly at 20.8% annually, this pace lags behind the broader Chinese market's forecast of 23.3%. However, revenue growth is robust, projected at 25.2% per year—outperforming both the company's earnings growth and the overall market rate.
In light of our recent growth report, it seems possible that HangzhouS MedTech's financial performance will exceed current levels.
Click here to discover the nuances of HangzhouS MedTech with our detailed financial health report.
Evergreen Aviation Technologies
Overview: Evergreen Aviation Technologies Corporation offers aircraft maintenance services to airline partners both in Taiwan and internationally, with a market cap of NT$40.27 billion.
Operations: The company's revenue is primarily derived from its Maintenance Segment, generating NT$13.47 billion, and its Manufacturing Segment, contributing NT$3.32 billion.
Estimated Discount To Fair Value: 43.3%
Evergreen Aviation Technologies, trading at NT$107.5, is undervalued compared to its fair value estimate of NT$195.16 based on discounted cash flow analysis. Despite a dividend yield of 4.19% not being fully covered by free cash flows, earnings are forecast to grow significantly at 27.81% annually, surpassing the Taiwanese market's growth rate of 13.3%. Recent regulatory fines and changes in board composition may impact short-term sentiment but don't overshadow long-term growth prospects.
Our earnings growth report unveils the potential for significant increases in Evergreen Aviation Technologies' future results.
Click to explore a detailed breakdown of our findings in Evergreen Aviation Technologies' balance sheet health report.
Key Takeaways
Click this link to deep-dive into the 482 companies within our Undervalued Global Stocks Based On Cash Flows screener.
Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.
Ready To Venture Into Other Investment Styles?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include KOSDAQ:A044490 SHSE:688581 and TWSE:2645.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Stock market today: Nasdaq, Dow, S&P 500, Nasdaq futures jump as Big Tech earnings, trade deals lift spirits
S&P 500 and Nasdaq futures surged on Thursday, setting sights on fresh record highs after strong Meta (META) and Microsoft (MSFT) earnings boosted faith in a payoff from Big Tech's massive AI investments. Contracts on the tech-heavy Nasdaq 100 (NQ=F) climbed roughly 1.4%, while those on the S&P 500 (ES=F) rose almost 1%. Dow Jones Industrial Average futures (YM=F) lagged, up 0.3%. Meta shares shot up 12% in premarket, as investors welcomed its earnings beat and stronger-than-expected guidance even as it ramps up its AI spending spree. Microsoft stock jumped over 8% after its impressive results, on track to make the company the second in the world to reach a $4 trillion market valuation. Markets are now looking to after-hours results from their "Magnificent Seven" peers Apple (AAPL) and Amazon (AMZN) for reasons to keep the rally going. On the macro front, investors will get another clue as to the possible direction of interest rates with the release of the Federal Reserve's preferred inflation gauge, the Personal Consumption Expenditures (PCE) index. Stocks were mixed in during the day Wednesday after the Fed held interest rates steady for its fifth-straight meeting, with two Fed governors dissenting. Following the decision, Fed Chair Jerome Powell stressed "no decisions" had been made about a September rate cut, undercutting President Trump's claim he had heard a cut was coming at policymakers' next meeting.. Meanwhile a flurry of trade deals eased trade-war fears on the eve of President Trump's deadline on Friday. A pact with South Korea announced late Wednesday sets a 15% tariff rate on its imports. US exports will face zero duties in return, and Seoul has agreed to make $350 billion in US investment and pledged to buy US energy products, Trump wrote in a social media post. A quirk in the Fed's calendar puts extra pressure on the Sept. meeting Yahoo Finance's Hamza Shaban takes a look at the Federal Reserve's next move in today's Morning Brief: Read more here on how a long wait could result in a different outlook. Good morning. Here's what's happening today. Economic data: Challenger jobs cuts (July); Personal income & spending (June); Core PCE price index; Employment cost index (second quarter); Initial jobless claims (week ending July 26) Earnings: Apple (AAPL), Amazon (AMZN), Bristol Myers Squibb (BMY), Cigna (CI), Coinbase (COIN), CVS Health (CVS), Mastercard (MA), Norwegian Cruise Line (NCLH), Reddit (RDDT), Roblox (RBLX), Roku (ROKU), Strategy (MSTR) Here are some of the biggest stories you may have missed overnight and early this morning: Trump knocks Canada as countries rush to strike trade deals Trump tariffs face another legal test on eve of deadline Apple faces 2 major threats ahead of earnings What's in the US-EU trade deal? It depends on who's talking. Fed calendar quirk raises the stakes for its Sept. meeting Meta stock surges after earnings beat, guidance surprise Microsoft on track for $4 trillion market cap after earnings beat Arm stock falls as chip ambitions shake investor confidence Trending tickers: ARM, CVS and Confluent Here are some top stocks trending on Yahoo Finance in premarket trading: Arm (ARM) stock fell 6% on Thursday before the bell following the announcement of the chip tech provider's plan to invest in its own chip development, which would bite into future profits, disappointed investors. CVS (CVS) stock jumped 7% in premarket on Thursday after the company beat Wall Street estimates for second-quarter profit. Confluent Inc (CFLT) stock rose over 20% premarket following the company's positive earnings report. The data streaming platform reported a 21% growth in subscription revenue and a 28% growth in Confluent Cloud revenue for Q2 2025. Carvana posts higher quarterly profit on record car sales Shares in Carvana (CVNA) surged over 15% in premarket trading after the online used-car seller defied expectations with strong second quarter results and outlook. Bloomberg reports: Read more here. EBay stock rises as resilient consumers fuel strong sales forecast EBay (EBAY) stock jumped on Thursday before the bell after the e-commerce company forecasted sales that topped analysts' estimates, suggesting optimism for continued consumer resilience at a time of shifting US tariff proposals. Bloomberg News reports: Read more here. AB InBev shares slide on concern over sales volumes Beer giant Anheuser-Busch InBev (BUD) stock slumped more than 9% before the bell on Thursday after reporting that its second quarter sales volumes fell more than expected due to weak demand in Brazil and China, adding to investor worries over industry growth and hitting its shares. Reuters reports: Read more here. Qualcomm on the move lower Qualcomm's (QCOM) not playing in the big-cap tech stock euphoria this morning led by Microsoft (MSFT) and Meta (META) post earnings. Its shares are down 6% premarket. The company's earnings late Wednesday were fine. But the Street is calling out a few things that are giving the bears the win, for now. This note from HSBC's Ryan Mellor this morning captures it all nicely: This is remarkable on Meta Meta's (META) stock is rocking higher in premarket, to the tune of 12% after a monster quarter. Got to love the market ignoring the capex stuff in its earnings release below, and focusing in on Meta's revenue trends (strong). "We currently expect 2025 capital expenditures, including principal payments on finance leases, to be in the range of $66-72 billion, narrowed from our prior outlook of $64-72 billion and up approximately $30 billion year-over-year at the mid-point. While the infrastructure planning process remains highly dynamic, we currently expect another year of similarly significant capital expenditures dollar growth in 2026 as we continue aggressively pursuing opportunities to bring additional capacity online to meet the needs of our artificial intelligence efforts and business operations," Meta said. Bottom line: bull market ... carry on! Microsoft earnings call: A quick take A bit of a sleepy earnings call from Microsoft (MSFT) after the close, filled with the typical Satya Nadella tech jargon. Bottom line is this: Azure sales crushed, and there was zero signs of peaking AI demand. That should be good enough for the bulls. "We expect stock to trade up given continued large Azure growth beats and a positive AI trajectory even with continued capacity constraints. We think this also bodes well for other AI infrastructure names in our coverage (Oracle (ORCL), Coreweave (CRWV)," Citi analyst Tyler Radke said. Samsung Electronics chip business fell drastically in Q2 Samsung Electronics ( saw a mammoth drop in profit from the chip-making arm of the electronics giant. Bloomberg reports: Read more here. A quirk in the Fed's calendar puts extra pressure on the Sept. meeting Yahoo Finance's Hamza Shaban takes a look at the Federal Reserve's next move in today's Morning Brief: Read more here on how a long wait could result in a different outlook. Yahoo Finance's Hamza Shaban takes a look at the Federal Reserve's next move in today's Morning Brief: Read more here on how a long wait could result in a different outlook. Good morning. Here's what's happening today. Economic data: Challenger jobs cuts (July); Personal income & spending (June); Core PCE price index; Employment cost index (second quarter); Initial jobless claims (week ending July 26) Earnings: Apple (AAPL), Amazon (AMZN), Bristol Myers Squibb (BMY), Cigna (CI), Coinbase (COIN), CVS Health (CVS), Mastercard (MA), Norwegian Cruise Line (NCLH), Reddit (RDDT), Roblox (RBLX), Roku (ROKU), Strategy (MSTR) Here are some of the biggest stories you may have missed overnight and early this morning: Trump knocks Canada as countries rush to strike trade deals Trump tariffs face another legal test on eve of deadline Apple faces 2 major threats ahead of earnings What's in the US-EU trade deal? It depends on who's talking. Fed calendar quirk raises the stakes for its Sept. meeting Meta stock surges after earnings beat, guidance surprise Microsoft on track for $4 trillion market cap after earnings beat Arm stock falls as chip ambitions shake investor confidence Economic data: Challenger jobs cuts (July); Personal income & spending (June); Core PCE price index; Employment cost index (second quarter); Initial jobless claims (week ending July 26) Earnings: Apple (AAPL), Amazon (AMZN), Bristol Myers Squibb (BMY), Cigna (CI), Coinbase (COIN), CVS Health (CVS), Mastercard (MA), Norwegian Cruise Line (NCLH), Reddit (RDDT), Roblox (RBLX), Roku (ROKU), Strategy (MSTR) Here are some of the biggest stories you may have missed overnight and early this morning: Trump knocks Canada as countries rush to strike trade deals Trump tariffs face another legal test on eve of deadline Apple faces 2 major threats ahead of earnings What's in the US-EU trade deal? It depends on who's talking. Fed calendar quirk raises the stakes for its Sept. meeting Meta stock surges after earnings beat, guidance surprise Microsoft on track for $4 trillion market cap after earnings beat Arm stock falls as chip ambitions shake investor confidence Trending tickers: ARM, CVS and Confluent Here are some top stocks trending on Yahoo Finance in premarket trading: Arm (ARM) stock fell 6% on Thursday before the bell following the announcement of the chip tech provider's plan to invest in its own chip development, which would bite into future profits, disappointed investors. CVS (CVS) stock jumped 7% in premarket on Thursday after the company beat Wall Street estimates for second-quarter profit. Confluent Inc (CFLT) stock rose over 20% premarket following the company's positive earnings report. The data streaming platform reported a 21% growth in subscription revenue and a 28% growth in Confluent Cloud revenue for Q2 2025. Here are some top stocks trending on Yahoo Finance in premarket trading: Arm (ARM) stock fell 6% on Thursday before the bell following the announcement of the chip tech provider's plan to invest in its own chip development, which would bite into future profits, disappointed investors. CVS (CVS) stock jumped 7% in premarket on Thursday after the company beat Wall Street estimates for second-quarter profit. Confluent Inc (CFLT) stock rose over 20% premarket following the company's positive earnings report. The data streaming platform reported a 21% growth in subscription revenue and a 28% growth in Confluent Cloud revenue for Q2 2025. Carvana posts higher quarterly profit on record car sales Shares in Carvana (CVNA) surged over 15% in premarket trading after the online used-car seller defied expectations with strong second quarter results and outlook. Bloomberg reports: Read more here. Shares in Carvana (CVNA) surged over 15% in premarket trading after the online used-car seller defied expectations with strong second quarter results and outlook. Bloomberg reports: Read more here. EBay stock rises as resilient consumers fuel strong sales forecast EBay (EBAY) stock jumped on Thursday before the bell after the e-commerce company forecasted sales that topped analysts' estimates, suggesting optimism for continued consumer resilience at a time of shifting US tariff proposals. Bloomberg News reports: Read more here. EBay (EBAY) stock jumped on Thursday before the bell after the e-commerce company forecasted sales that topped analysts' estimates, suggesting optimism for continued consumer resilience at a time of shifting US tariff proposals. Bloomberg News reports: Read more here. AB InBev shares slide on concern over sales volumes Beer giant Anheuser-Busch InBev (BUD) stock slumped more than 9% before the bell on Thursday after reporting that its second quarter sales volumes fell more than expected due to weak demand in Brazil and China, adding to investor worries over industry growth and hitting its shares. Reuters reports: Read more here. Beer giant Anheuser-Busch InBev (BUD) stock slumped more than 9% before the bell on Thursday after reporting that its second quarter sales volumes fell more than expected due to weak demand in Brazil and China, adding to investor worries over industry growth and hitting its shares. Reuters reports: Read more here. Qualcomm on the move lower Qualcomm's (QCOM) not playing in the big-cap tech stock euphoria this morning led by Microsoft (MSFT) and Meta (META) post earnings. Its shares are down 6% premarket. The company's earnings late Wednesday were fine. But the Street is calling out a few things that are giving the bears the win, for now. This note from HSBC's Ryan Mellor this morning captures it all nicely: Qualcomm's (QCOM) not playing in the big-cap tech stock euphoria this morning led by Microsoft (MSFT) and Meta (META) post earnings. Its shares are down 6% premarket. The company's earnings late Wednesday were fine. But the Street is calling out a few things that are giving the bears the win, for now. This note from HSBC's Ryan Mellor this morning captures it all nicely: This is remarkable on Meta Meta's (META) stock is rocking higher in premarket, to the tune of 12% after a monster quarter. Got to love the market ignoring the capex stuff in its earnings release below, and focusing in on Meta's revenue trends (strong). "We currently expect 2025 capital expenditures, including principal payments on finance leases, to be in the range of $66-72 billion, narrowed from our prior outlook of $64-72 billion and up approximately $30 billion year-over-year at the mid-point. While the infrastructure planning process remains highly dynamic, we currently expect another year of similarly significant capital expenditures dollar growth in 2026 as we continue aggressively pursuing opportunities to bring additional capacity online to meet the needs of our artificial intelligence efforts and business operations," Meta said. Bottom line: bull market ... carry on! Meta's (META) stock is rocking higher in premarket, to the tune of 12% after a monster quarter. Got to love the market ignoring the capex stuff in its earnings release below, and focusing in on Meta's revenue trends (strong). "We currently expect 2025 capital expenditures, including principal payments on finance leases, to be in the range of $66-72 billion, narrowed from our prior outlook of $64-72 billion and up approximately $30 billion year-over-year at the mid-point. While the infrastructure planning process remains highly dynamic, we currently expect another year of similarly significant capital expenditures dollar growth in 2026 as we continue aggressively pursuing opportunities to bring additional capacity online to meet the needs of our artificial intelligence efforts and business operations," Meta said. Bottom line: bull market ... carry on! Microsoft earnings call: A quick take A bit of a sleepy earnings call from Microsoft (MSFT) after the close, filled with the typical Satya Nadella tech jargon. Bottom line is this: Azure sales crushed, and there was zero signs of peaking AI demand. That should be good enough for the bulls. "We expect stock to trade up given continued large Azure growth beats and a positive AI trajectory even with continued capacity constraints. We think this also bodes well for other AI infrastructure names in our coverage (Oracle (ORCL), Coreweave (CRWV)," Citi analyst Tyler Radke said. A bit of a sleepy earnings call from Microsoft (MSFT) after the close, filled with the typical Satya Nadella tech jargon. Bottom line is this: Azure sales crushed, and there was zero signs of peaking AI demand. That should be good enough for the bulls. "We expect stock to trade up given continued large Azure growth beats and a positive AI trajectory even with continued capacity constraints. We think this also bodes well for other AI infrastructure names in our coverage (Oracle (ORCL), Coreweave (CRWV)," Citi analyst Tyler Radke said. Samsung Electronics chip business fell drastically in Q2 Samsung Electronics ( saw a mammoth drop in profit from the chip-making arm of the electronics giant. Bloomberg reports: Read more here. Samsung Electronics ( saw a mammoth drop in profit from the chip-making arm of the electronics giant. Bloomberg reports: Read more here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28 minutes ago
- Yahoo
Investing in Artificial Intelligence (AI) Stocks Can Be Risky, but This Might Be a Great Way to Do It
Key Points Volatility is the price we pay for the opportunity to earn higher returns in the stock market compared to risk-free assets like cash. Artificial intelligence (AI) stocks have generally delivered spectacular returns over the last couple of years, but it isn't always smooth sailing. The iShares Future AI and Technology ETF holds 48 different AI stocks, and it might be a great option for investors seeking exposure to the sector. 10 stocks we like better than iShares Future AI & Tech ETF › Investors can earn a reliable, practically risk-free annual return of up to 5% by purchasing U.S. government bonds, or they can invest in the S&P 500 (SNPINDEX: ^GSPC) index, which has delivered a compound annual return of 10.5% since its inception in 1957. But volatility is the price we pay for higher returns in the stock market, so investors will have to stomach regular sell-offs along the way, which sometimes exceed 20%. Those risks are substantially higher when investing in hyper-growth areas like artificial intelligence (AI). AI software powerhouse Palantir Technologies (NASDAQ: PLTR) offers a great example -- its stock has surged by a whopping 480% over the past 12 months, but it suffered a nerve-racking plunge of 40% between February and April this year, which would have spooked even the most seasoned investors. Buying an exchange-traded fund (ETF) can be a great way to invest in a basket of high-growth AI stocks, while smoothing out some of that extreme volatility. The iShares Future AI and Technology ETF (NYSEMKT: ARTY) holds 48 different AI stocks, including many of the industry's leaders, so it can insulate investors from sharp losses if one or two names underperform. Read on to learn more. Palantir, Nvidia, and Alphabet are just some of the AI leaders in this ETF The iShares Future AI and Technology ETF focuses on the entire AI value chain, investing in companies all over the world that develop the infrastructure, software, and services powering this tech boom. The below table displays 10 of the most notable AI names in the ETF's 48-stock portfolio, ordered by their weightings: Stock iShares ETF Portfolio Weighting Advanced Micro Devices (NASDAQ: AMD) 5.66% Nvidia (NASDAQ: NVDA) 5.04% Broadcom (NASDAQ: AVGO) 4.82% Palantir Technologies 3.29% Alphabet Class A (NASDAQ: GOOGL) 3.01% Microsoft (NASDAQ: MSFT) 3.00% Amazon (NASDAQ: AMZN) 2.94% Snowflake (NYSE: SNOW) 2.85% Meta Platforms (NASDAQ: META) 2.51% Oracle (NYSE: ORCL) 0.64% Data source: iShares. Portfolio weightings are accurate as of July 25, 2025, and are subject to change. The AI revolution really gathered momentum at the start of 2023, when OpenAI's ChatGPT application surged in popularity by giving people a glimpse into this technology's potential. Since then, the above stocks have delivered a blistering average return of 522%, and a median return of 185%, so investors who haven't owned a slice of the AI boom have almost certainly underperformed the broader market: AMD, Nvidia, and Broadcom are three top suppliers of the data center chips, networking equipment, and components required to develop AI. Nvidia is the clear leader of that pack because the performance of its graphics processing units (GPUs) is unmatched, and demand for those chips continues to exceed supply. In fact, Nvidia has become the world's largest company on the back of the AI revolution, with its market capitalization recently topping $4.3 trillion. Alphabet, Microsoft, and Amazon are some of the biggest buyers of the data center hardware I just highlighted. They each operate cloud platforms where they sell state-of-the-art computing capacity to AI developers, in addition to ready-made large language models (LLMs), which are the core ingredients for creating AI software. Then there is Palantir, which is a true AI software giant. Its AIP (Artificial Intelligence Platform) platform helps businesses and governments deploy AI into their operations, whereas its Gotham and Foundry platforms help them extract valuable insights from their data. The more than 20-fold increase in Palantir stock since the start of 2023 has catapulted it to a very high -- and potentially unsustainable -- valuation, but that hasn't stopped one Wall Street analyst from predicting more upside. A great addition to a diversified portfolio The performance of the iShares Future AI and Technology ETF is completely dependent on the success of AI and AI-adjacent technologies, so investors shouldn't put all of their eggs in one basket even though it's less risky than buying one or two AI stocks. Instead, they should buy it as part of a diversified portfolio of other funds or individual stocks. Moreover, the ETF was established in 2018 with a broad focus on robotics and AI, but it was completely reconstructed on Aug. 12 last year to focus on AI specifically. Therefore, it doesn't have much of a track record for investors to analyze, but it has delivered a massive return of 40% since the changes were made. That's more than double the 19.5% return produced by the S&P 500 over the same period. That strong performance does come at a cost, because the iShares ETF has an expense ratio of 0.47%. It means a $10,000 investment will incur an annual fee of $47, which doesn't sound high at face value, but a traditional index fund issued by a company like Vanguard typically comes with an expense ratio of just 0.03%. This cost won't matter much if the iShares ETF continues to deliver blistering returns, but it's something to consider. One thing is for sure: The iShares ETF currently holds every AI stock an investor could want, so it will make a great addition to a diversified portfolio, especially one that doesn't already have exposure to this revolutionary sector of the market. Should you buy stock in iShares Future AI & Tech ETF right now? Before you buy stock in iShares Future AI & Tech ETF, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and iShares Future AI & Tech ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $630,291!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,075,791!* Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Anthony Di Pizio has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Amazon, Meta Platforms, Microsoft, Nvidia, Oracle, Palantir Technologies, and Snowflake. The Motley Fool recommends Broadcom and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Investing in Artificial Intelligence (AI) Stocks Can Be Risky, but This Might Be a Great Way to Do It was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Eli Lilly (LLY) Declines More Than Market: Some Information for Investors
In the latest trading session, Eli Lilly (LLY) closed at $762.95, marking a -5.59% move from the previous day. This change lagged the S&P 500's daily loss of 0.3%. On the other hand, the Dow registered a loss of 0.46%, and the technology-centric Nasdaq decreased by 0.38%. The drugmaker's shares have seen an increase of 3.67% over the last month, surpassing the Medical sector's gain of 0.76% and the S&P 500's gain of 3.64%. The upcoming earnings release of Eli Lilly will be of great interest to investors. The company's earnings report is expected on August 7, 2025. It is anticipated that the company will report an EPS of $5.61, marking a 43.11% rise compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $14.75 billion, indicating a 30.49% growth compared to the corresponding quarter of the prior year. For the full year, the Zacks Consensus Estimates are projecting earnings of $22.05 per share and revenue of $60.55 billion, which would represent changes of +69.75% and +34.43%, respectively, from the prior year. Any recent changes to analyst estimates for Eli Lilly should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 0.48% higher within the past month. As of now, Eli Lilly holds a Zacks Rank of #3 (Hold). With respect to valuation, Eli Lilly is currently being traded at a Forward P/E ratio of 36.64. This indicates a premium in contrast to its industry's Forward P/E of 14.23. Also, we should mention that LLY has a PEG ratio of 1.15. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The average PEG ratio for the Large Cap Pharmaceuticals industry stood at 1.24 at the close of the market yesterday. The Large Cap Pharmaceuticals industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 62, placing it within the top 26% of over 250 industries. The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow LLY in the coming trading sessions, be sure to utilize Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Eli Lilly and Company (LLY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
